Flubendazole

Flubendazole

SCHEMBL28086273

COC(=O)Nc1nc2ccc(C(=O)C3CC3)cc2[nH]1.COC(=O)Nc1nc2ccc(C(=O)c3ccc(F)cc3)cc2[nH]1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.82
MAPK1 P28482 2/20 0.82
ADORA3 P0DMS8 1/20 0.82
PTGS1 P23219 1/20 0.82
RXFP1 Q9HBX9 1/20 0.82
ALDH1A1 P00352 2/20 0.67
ABL1 P00519 2/20 0.67
LMNA P02545 2/20 0.67
CYP1A2 P05177 2/20 0.67
CYP2C9 P11712 2/20 0.67
HTT P42858 2/20 0.67
HIF1A Q16665 2/20 0.67
ABCC4 O15439 1/20 0.67
USP2 O75604 1/20 0.67
TUBB4A P04350 3/20 0.56
TUBB P07437 3/20 0.56
TUBA3C P0DPH7 3/20 0.56
TUBA1B P68363 3/20 0.56
TUBA4A P68366 3/20 0.56
TUBB4B P68371 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flubendazole SCHEMBL20815724 0.92 KDR (0.69) KDRMAPK1ADORA3PTGS1RXFP1
Flubendazole SCHEMBL6232065 0.91 KDR (1.00) KDRMAPK1ADORA3PTGS1RXFP1
Flubendazole SCHEMBL31704404 0.91 KDR (1.00) KDRMAPK1ADORA3PTGS1RXFP1
Cyclobendazole SCHEMBL1649791 0.91 LMNA (0.65) KDRMAPK1ADORA3PTGS1RXFP1
Cyclobendazole SCHEMBL31544741 0.91 LMNA (0.65) KDRMAPK1ADORA3PTGS1RXFP1
Cyclobendazole SCHEMBL159525 0.82 LMNA (0.53) KDRMAPK1ADORA3PTGS1RXFP1
Flubendazole SCHEMBL29409278 0.82 KDR (0.82) KDRMAPK1ADORA3PTGS1RXFP1
Flubendazole SCHEMBL167185 0.82 KDR (0.82) KDRMAPK1ADORA3PTGS1RXFP1
Flubendazole SCHEMBL22321861 0.81 KDR (0.80) KDRMAPK1ADORA3PTGS1RXFP1
Mebendazole SCHEMBL29390263 0.81 ABL1 (1.00) KDRMAPK1ADORA3PTGS1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed